We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$198B
AUM Growth
+$712M
Cap. Flow
-$3.16B
Cap. Flow %
-1.6%
Top 10 Hldgs %
21.74%
Holding
10,995
New
1,488
Increased
3,477
Reduced
3,725
Closed
2,170

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.13%
2 Healthcare 1.22%
3 Technology 1.15%
4 Consumer Discretionary 1.1%
5 Financials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMEI
8151
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$155K ﹤0.01%
4,193
-30,708
-88% -$1.28M
CXRX
8152
CALL
DELISTED
Concordia International Corp. Common Stock
CXRX
$155K ﹤0.01%
95,200
-20,700
-18% -$44.6K
ACTG icon
8153
CALL
Acacia Research
ACTG
$436M
$154K ﹤0.01%
26,700
-31,700
-54% -$185K
DMK
8154
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$154K ﹤0.01%
517
-699
-57% -$176K
ECOM
8155
CALL
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$154K ﹤0.01%
13,800
-37,100
-73% -$458K
VG
8156
CALL
DELISTED
Vonage Holdings Corporation
VG
$154K ﹤0.01%
24,400
-181,500
-88% -$1.21M
CSCI
8157
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$153K ﹤0.01%
+509
New +$150K
BDSI
8158
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$153K ﹤0.01%
80,300
-1,200
-1% -$2.31K
CLIR icon
8159
CALL
ClearSign Technologies
CLIR
$31.5M
$152K ﹤0.01%
3,910
+2,310
+144% +$83.4K
EXTR icon
8160
PUT
Extreme Networks
EXTR
$2.92B
$152K ﹤0.01%
+20,300
New +$122K
SPWH icon
8161
Sportsman's Warehouse
SPWH
$44.9M
$152K ﹤0.01%
31,812
-43,389
-58% -$270K
AMRI
8162
PUT
DELISTED
Albany Molecular Research Inc
AMRI
$152K ﹤0.01%
10,800
-100
-0.9% -$1.64K
INVA icon
8163
PUT
Innoviva
INVA
$1.51B
$151K ﹤0.01%
10,900
-9,100
-46% -$107K
MLPA icon
8164
Global X MLP ETF
MLPA
$2.37B
$151K ﹤0.01%
2,160
-9,623
-82% -$677K
MOD icon
8165
PUT
Modine Manufacturing
MOD
$9.49B
$151K ﹤0.01%
+12,400
New +$154K
TDW icon
8166
CALL
Tidewater
TDW
$4.61B
$151K ﹤0.01%
4,080
+558
+16% +$31.7K
ECT
8167
CALL
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$151K ﹤0.01%
70,400
-37,200
-35% -$88.6K
GAU
8168
CALL
Galiano Gold
GAU
$599M
$150K ﹤0.01%
57,400
-1,200
-2% -$3.71K
VLY icon
8169
PUT
Valley National Bancorp
VLY
$7.65B
$150K ﹤0.01%
+12,700
New +$152K
SCU
8170
PUT
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$150K ﹤0.01%
6,630
+1,440
+28% +$42.6K
NYRT
8171
PUT
DELISTED
New York REIT, Inc.
NYRT
$150K ﹤0.01%
1,550
-2,550
-62% -$251K
GNRT
8172
PUT
DELISTED
Gener8 Maritime, Inc.
GNRT
$150K ﹤0.01%
26,500
+7,700
+41% +$38.4K
BBW icon
8173
CALL
Build-A-Bear
BBW
$365M
$149K ﹤0.01%
16,800
-40,500
-71% -$431K
ASXC
8174
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$149K ﹤0.01%
9,485
+1,970
+26% +$34.1K
CCLP
8175
PUT
DELISTED
CSI Compressco LP
CCLP
$149K ﹤0.01%
+15,200
New +$162K

Similar funds

Jeff Yass's Q1 2017 Portfolio in Review

As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jeff Yass's Q1 2017 filing shows 1,488 new, 3,477 increased, 3,725 reduced and 2,170 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M. The largest sale was Apple, an estimated $1.82B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Healthcare and Technology.

  • Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
  • Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
  • Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
  • Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
  • Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
  • Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.